1
|
Zhang Z, Chen K, Ameduri B, Chen M. Fluoropolymer Nanoparticles Synthesized via Reversible-Deactivation Radical Polymerizations and Their Applications. Chem Rev 2023; 123:12431-12470. [PMID: 37906708 DOI: 10.1021/acs.chemrev.3c00350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2023]
Abstract
Fluorinated polymeric nanoparticles (FPNPs) combine unique properties of fluorocarbon and polymeric nanoparticles, which has stimulated massive interest for decades. However, fluoropolymers are not readily available from nature, resulting in synthetic developments to obtain FPNPs via free radical polymerizations. Recently, while increasing cutting-edge directions demand tailored FPNPs, such materials have been difficult to access via conventional approaches. Reversible-deactivation radical polymerizations (RDRPs) are powerful methods to afford well-defined polymers. Researchers have applied RDRPs to the fabrication of FPNPs, enabling the construction of particles with improved complexity in terms of structure, composition, morphology, and functionality. Related examples can be classified into three categories. First, well-defined fluoropolymers synthesized via RDRPs have been utilized as precursors to form FPNPs through self-folding and solution self-assembly. Second, thermally and photoinitiated RDRPs have been explored to realize in situ preparations of FPNPs with varied morphologies via polymerization-induced self-assembly and cross-linking copolymerization. Third, grafting from inorganic nanoparticles has been investigated based on RDRPs. Importantly, those advancements have promoted studies toward promising applications, including magnetic resonance imaging, biomedical delivery, energy storage, adsorption of perfluorinated alkyl substances, photosensitizers, and so on. This Review should present useful knowledge to researchers in polymer science and nanomaterials and inspire innovative ideas for the synthesis and applications of FPNPs.
Collapse
Affiliation(s)
- Zexi Zhang
- Department of Macromolecular Science, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200438, China
| | - Kaixuan Chen
- Department of Macromolecular Science, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200438, China
| | - Bruno Ameduri
- Institute Charles Gerhardt of Montpellier (ICGM), CNRS, University of Montpellier, ENSCM, Montpellier 34296, France
| | - Mao Chen
- Department of Macromolecular Science, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200438, China
| |
Collapse
|
2
|
Zhao Y, Liu T, Ardana A, Fletcher NL, Houston ZH, Blakey I, Thurecht KJ. Investigation of a Dual siRNA/Chemotherapy Delivery System for Breast Cancer Therapy. ACS OMEGA 2022; 7:17119-17127. [PMID: 35647423 PMCID: PMC9134248 DOI: 10.1021/acsomega.2c00620] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/30/2022] [Accepted: 04/26/2022] [Indexed: 06/15/2023]
Abstract
Multidrug resistance (MDR) is a problem that is often associated with a poor clinical outcome in chemotherapeutic cancer treatment. MDR may potentially be overcome by utilizing synergistic approaches, such as combining siRNA gene therapy and chemotherapy to target different mechanisms of apoptosis. In this study, a strategy is presented for developing multicomponent nanomedicines using orthogonal and compatible chemistries that lead to effective nanotherapeutics. Hyperbranched polymers were used as drug carriers that contained doxorubicin (DOX), attached via a pH-sensitive hydrazone linkage, and ataxia-telangiectasia mutated (ATM) siRNA, attached via a redox-sensitive disulfide group. This nanomedicine also contained cyanine 5 (Cy5) as a diagnostic tracer as well as in-house developed bispecific antibodies that allowed targeting of the epidermal growth factor receptor (EGFR) present on tumor tissue. Highly efficient coupling of siRNA was achieved with 80% of thiol end-groups on the hyperbranched polymer coupling with siRNA. This attachment was reversible, with the majority of siRNA released in vitro under reducing conditions as desired. In cellular studies, the nanomedicine exhibited increased DNA damage and cancer cell inhibition compared to the individual treatments. Moreover, the nanomedicine has great potential to suppress the metabolism of cancer cells including both mitochondrial respiration and glycolytic activity, with enhanced efficacy observed when targeted to the cell surface protein EGFR. Our findings indicated that co-delivery of ATM siRNA and DOX serves as a more efficient therapeutic avenue in cancer treatment than delivery of the single species and offers a potential route for synergistically enhanced gene therapy.
Collapse
Affiliation(s)
- Yongmei Zhao
- School
of Pharmacy, Nantong University, Nantong 226019 China
| | - Tianqing Liu
- QIMR
Berghofer Medical Research, 300 Herston Rd, Brisbane, QLD 4006 Australia
| | - Aditya Ardana
- Commonwealth
Scientific and Industrial Research Organisation, Parkville Campus, Canberra, ACT, 2601, Australia
| | - Nicholas L. Fletcher
- Centre
for Advanced Imaging, Australian Institute for Bioengineering and
Nanotechnology, ARC Centre of Excellence in Convergent Bio-Nano Science
and Technology and ARC Training Centre in Biomedical Imaging Technology, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Zachary H. Houston
- Centre
for Advanced Imaging, Australian Institute for Bioengineering and
Nanotechnology, ARC Centre of Excellence in Convergent Bio-Nano Science
and Technology and ARC Training Centre in Biomedical Imaging Technology, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Idriss Blakey
- Centre
for Advanced Imaging, Australian Institute for Bioengineering and
Nanotechnology, ARC Centre of Excellence in Convergent Bio-Nano Science
and Technology and ARC Training Centre in Biomedical Imaging Technology, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Kristofer J. Thurecht
- Centre
for Advanced Imaging, Australian Institute for Bioengineering and
Nanotechnology, ARC Centre of Excellence in Convergent Bio-Nano Science
and Technology and ARC Training Centre in Biomedical Imaging Technology, The University of Queensland, Brisbane, QLD 4072, Australia
| |
Collapse
|
3
|
Yang C, Lin ZI, Chen JA, Xu Z, Gu J, Law WC, Yang JHC, Chen CK. Organic/Inorganic Self-Assembled Hybrid Nano-Architectures for Cancer Therapy Applications. Macromol Biosci 2021; 22:e2100349. [PMID: 34735739 DOI: 10.1002/mabi.202100349] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2021] [Revised: 10/25/2021] [Indexed: 12/20/2022]
Abstract
Since the conceptualization of nanomedicine, numerous nanostructure-mediated drug formulations have progressed into clinical trials for treating cancer. However, recent clinical trial results indicate such kind of drug formulations has a limited improvement on the antitumor efficacy. This is due to the biological barriers associated with those formulations, for example, circulation stability, extravasation efficiency in tumor, tumor penetration ability, and developed multi-drug resistance. When employing for nanomedicine formulations, pristine organic-based and inorganic-based nanostructures have their own limitations. Accordingly, organic/inorganic (O/I) hybrids have been developed to integrate the merits of both, and to minimize their intrinsic drawbacks. In this context, the recent development in O/I hybrids resulting from a self-assembly strategy will be introduced. Through such a strategy, organic and inorganic building blocks can be self-assembled via either chemical covalent bonds or physical interactions. Based on the self-assemble procedure, the hybridization of four organic building blocks including liposomes, micelles, dendrimers, and polymeric nanocapsules with five functional inorganic nanoparticles comprising gold nanostructures, magnetic nanoparticles, carbon-based materials, quantum dots, and silica nanoparticles will be highlighted. The recent progress of these O/I hybrids in advanced modalities for combating cancer, such as, therapeutic agent delivery, photothermal therapy, photodynamic therapy, and immunotherapy will be systematically reviewed.
Collapse
Affiliation(s)
- Chengbin Yang
- Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, 518060, China
| | - Zheng-Ian Lin
- Polymeric Biomaterials Laboratory, Department of Materials and Optoelectronic Science, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan
| | - Jian-An Chen
- Polymeric Biomaterials Laboratory, Department of Materials and Optoelectronic Science, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan
| | - Zhourui Xu
- Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, 518060, China
| | - Jiayu Gu
- Department of Pharmacy, The Second Clinical Medical College (Shenzhen People's Hospital), Jinan University, Shenzhen, 518020, China
| | - Wing-Cheung Law
- Department of Industrial and Systems Engineering, The Hong Kong Polytechnic University, Hung Hom, Hong Kong, China
| | - Jason Hsiao Chun Yang
- Department of Fiber and Composite Materials, Feng Chia University, Taichung, 40724, Taiwan
| | - Chih-Kuang Chen
- Polymeric Biomaterials Laboratory, Department of Materials and Optoelectronic Science, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan
| |
Collapse
|
4
|
Reis M, Gusev F, Taylor NG, Chung SH, Verber MD, Lee YZ, Isayev O, Leibfarth FA. Machine-Learning-Guided Discovery of 19F MRI Agents Enabled by Automated Copolymer Synthesis. J Am Chem Soc 2021; 143:17677-17689. [PMID: 34637304 PMCID: PMC10833148 DOI: 10.1021/jacs.1c08181] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Modern polymer science suffers from the curse of multidimensionality. The large chemical space imposed by including combinations of monomers into a statistical copolymer overwhelms polymer synthesis and characterization technology and limits the ability to systematically study structure-property relationships. To tackle this challenge in the context of 19F magnetic resonance imaging (MRI) agents, we pursued a computer-guided materials discovery approach that combines synergistic innovations in automated flow synthesis and machine learning (ML) method development. A software-controlled, continuous polymer synthesis platform was developed to enable iterative experimental-computational cycles that resulted in the synthesis of 397 unique copolymer compositions within a six-variable compositional space. The nonintuitive design criteria identified by ML, which were accomplished by exploring <0.9% of the overall compositional space, lead to the identification of >10 copolymer compositions that outperformed state-of-the-art materials.
Collapse
Affiliation(s)
- Marcus Reis
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Filipp Gusev
- Department of Chemistry, Mellon College of Science, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States
- Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States
| | - Nicholas G Taylor
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Sang Hun Chung
- Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Matthew D Verber
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Yueh Z Lee
- Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Olexandr Isayev
- Department of Chemistry, Mellon College of Science, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States
- Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States
| | - Frank A Leibfarth
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| |
Collapse
|
5
|
Marasini N, Fu C, Fletcher NL, Subasic C, Er G, Mardon K, Thurecht KJ, Whittaker AK, Kaminskas LM. The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats. NANOMATERIALS (BASEL, SWITZERLAND) 2020; 10:E2452. [PMID: 33302413 PMCID: PMC7762536 DOI: 10.3390/nano10122452] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Revised: 12/02/2020] [Accepted: 12/03/2020] [Indexed: 11/17/2022]
Abstract
A better understanding of the impact of molecular size and linkers is important for PEG-based hyperbranched polymers (HBPs) intended as tailored drug delivery vehicles. This study aimed to evaluate the effects of crosslinker chemistry (cleavable disulphide versus non-cleavable ethylene glycol methacrylate (EGDMA) linkers) and molecular weight within the expected size range for efficient renal elimination (22 vs. 48 kDa) on the intravenous pharmacokinetic and biodistribution properties of 89Zr-labelled HBPs in rats. All HBPs showed similar plasma pharmacokinetics over 72 h, despite differences in linker chemistry and size. A larger proportion of HBP with the cleavable linker was eliminated via the urine and faeces compared to a similar-sized HBP with the non-cleavable linker, while size had no impact on the proportion of the dose excreted. The higher molecular weight HBPs accumulated in organs of the mononuclear phagocyte system (liver and spleen) more avidly than the smaller HBP. These results suggest that HBPs within the 22 to 48 kDa size range show no differences in plasma pharmacokinetics, but distinct patterns of organ biodistribution and elimination are evident.
Collapse
Affiliation(s)
- Nirmal Marasini
- School of Biomedical Sciences, The University of Queensland, St Lucia 4072, Queensland, Australia;
| | - Changkui Fu
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia 4072, Queensland, Australia; (C.F.); (N.L.F.); (G.E.); (K.J.T.); (A.K.W.)
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, St Lucia 4072, Queensland, Australia
| | - Nicholas L. Fletcher
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia 4072, Queensland, Australia; (C.F.); (N.L.F.); (G.E.); (K.J.T.); (A.K.W.)
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, St Lucia 4072, Queensland, Australia
- ARC Training Centre for innovation in Biomedical Imaging Technology, The University of Queensland, St Lucia 4072, Queensland, Australia
- Centre for Advance Imaging, The University of Queensland, St Lucia 4072, Queensland, Australia;
| | - Christopher Subasic
- School of Biomedical Sciences, The University of Queensland, St Lucia 4072, Queensland, Australia;
| | - Gerald Er
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia 4072, Queensland, Australia; (C.F.); (N.L.F.); (G.E.); (K.J.T.); (A.K.W.)
| | - Karine Mardon
- Centre for Advance Imaging, The University of Queensland, St Lucia 4072, Queensland, Australia;
| | - Kristofer J. Thurecht
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia 4072, Queensland, Australia; (C.F.); (N.L.F.); (G.E.); (K.J.T.); (A.K.W.)
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, St Lucia 4072, Queensland, Australia
- ARC Training Centre for innovation in Biomedical Imaging Technology, The University of Queensland, St Lucia 4072, Queensland, Australia
- Centre for Advance Imaging, The University of Queensland, St Lucia 4072, Queensland, Australia;
| | - Andrew K. Whittaker
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia 4072, Queensland, Australia; (C.F.); (N.L.F.); (G.E.); (K.J.T.); (A.K.W.)
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, St Lucia 4072, Queensland, Australia
| | - Lisa M. Kaminskas
- School of Biomedical Sciences, The University of Queensland, St Lucia 4072, Queensland, Australia;
| |
Collapse
|
6
|
Humphries J, Pizzi D, Sonderegger SE, Fletcher NL, Houston ZH, Bell CA, Kempe K, Thurecht KJ. Hyperbranched Poly(2-oxazoline)s and Poly(ethylene glycol): A Structure–Activity Comparison of Biodistribution. Biomacromolecules 2020; 21:3318-3331. [DOI: 10.1021/acs.biomac.0c00765] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- James Humphries
- Centre for Advanced Imaging, The University of Queensland, Brisbane, Queensland 4072, Australia
- Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland 4072, Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, Brisbane, Queensland 4072, Australia
| | - David Pizzi
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia
| | - Stefan E. Sonderegger
- Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland 4072, Australia
| | - Nicholas L. Fletcher
- Centre for Advanced Imaging, The University of Queensland, Brisbane, Queensland 4072, Australia
- Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland 4072, Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, Brisbane, Queensland 4072, Australia
| | - Zachary H. Houston
- Centre for Advanced Imaging, The University of Queensland, Brisbane, Queensland 4072, Australia
- Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland 4072, Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, Brisbane, Queensland 4072, Australia
| | - Craig A. Bell
- Centre for Advanced Imaging, The University of Queensland, Brisbane, Queensland 4072, Australia
- Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland 4072, Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, Brisbane, Queensland 4072, Australia
| | - Kristian Kempe
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia
- Materials Science and Engineering, Monash University, Clayton, Victoria 3800, Australia
| | - Kristofer J. Thurecht
- Centre for Advanced Imaging, The University of Queensland, Brisbane, Queensland 4072, Australia
- Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland 4072, Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, Brisbane, Queensland 4072, Australia
- ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland, Brisbane, Queensland 4072, Australia
| |
Collapse
|
7
|
Ediriweera GR, Simpson JD, Fuchs AV, Venkatachalam TK, Van De Walle M, Howard CB, Mahler SM, Blinco JP, Fletcher NL, Houston ZH, Bell CA, Thurecht KJ. Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery. Chem Sci 2020; 11:3268-3280. [PMID: 34122834 PMCID: PMC8157365 DOI: 10.1039/d0sc00078g] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
There remain several key challenges to existing therapeutic systems for cancer therapy, such as quantitatively determining the true, tissue-specific drug release profile in vivo, as well as reducing side-effects for an increased standard of care. Hence, it is crucial to engineer new materials that allow for a better understanding of the in vivo pharmacokinetic/pharmacodynamic behaviours of therapeutics. We have expanded on recent “click-to-release” bioorthogonal pro-drug activation of antibody-drug conjugates (ADCs) to develop a modular and controlled theranostic system for quantitatively assessing site-specific drug activation and deposition from a nanocarrier molecule, by employing defined chemistries. The exploitation of quantitative imaging using positron emission tomography (PET) together with pre-targeted bioorthogonal chemistries in our system provided an effective means to assess in real-time the exact amount of active drug administered at precise sites in the animal; our methodology introduces flexibility in both the targeting and therapeutic components that is specific to nanomedicines and offers unique advantages over other technologies. In this approach, the in vivo click reaction facilitates pro-drug activation as well as provides a quantitative means to investigate the dynamic behaviour of the therapeutic agent. There remain several key challenges to existing therapeutic systems for cancer therapy, such as quantitatively determining the true, tissue-specific drug release profile in vivo, as well as reducing side-effects for an increased standard of care.![]()
Collapse
Affiliation(s)
- Gayathri R Ediriweera
- Centre for Advanced Imaging, The University of Queensland Brisbane QLD 4072 Australia .,Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.,ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland Brisbane QLD 4072 Australia
| | - Joshua D Simpson
- Centre for Advanced Imaging, The University of Queensland Brisbane QLD 4072 Australia .,Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.,ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland Brisbane QLD 4072 Australia
| | - Adrian V Fuchs
- Centre for Advanced Imaging, The University of Queensland Brisbane QLD 4072 Australia .,Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.,ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland Brisbane QLD 4072 Australia
| | - Taracad K Venkatachalam
- Centre for Advanced Imaging, The University of Queensland Brisbane QLD 4072 Australia .,Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.,ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland Brisbane QLD 4072 Australia
| | - Matthias Van De Walle
- School of Chemistry, Physics and Mechanical Engineering, Queensland University of Technology 2 George St Brisbane QLD 4000 Australia
| | - Christopher B Howard
- Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.,ARC Training Centre for Biopharmaceutical Innovation, The University of Queensland Brisbane QLD 4072 Australia
| | - Stephen M Mahler
- Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.,ARC Training Centre for Biopharmaceutical Innovation, The University of Queensland Brisbane QLD 4072 Australia
| | - James P Blinco
- School of Chemistry, Physics and Mechanical Engineering, Queensland University of Technology 2 George St Brisbane QLD 4000 Australia
| | - Nicholas L Fletcher
- Centre for Advanced Imaging, The University of Queensland Brisbane QLD 4072 Australia .,Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.,ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland Brisbane QLD 4072 Australia
| | - Zachary H Houston
- Centre for Advanced Imaging, The University of Queensland Brisbane QLD 4072 Australia .,Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.,ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland Brisbane QLD 4072 Australia
| | - Craig A Bell
- Centre for Advanced Imaging, The University of Queensland Brisbane QLD 4072 Australia .,Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.,ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland Brisbane QLD 4072 Australia
| | - Kristofer J Thurecht
- Centre for Advanced Imaging, The University of Queensland Brisbane QLD 4072 Australia .,Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.,ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland Brisbane QLD 4072 Australia
| |
Collapse
|
8
|
Kang C, Kim D. Nanoconfinement-mediated cancer theranostics. Arch Pharm Res 2020; 43:110-117. [PMID: 31989481 DOI: 10.1007/s12272-020-01217-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Accepted: 01/20/2020] [Indexed: 10/25/2022]
Abstract
Despite various therapeutic or diagnostic developments, cancer is still one of the most lethal diseases due to insufficiently adequate treatments and the delay of the early stage of disease detection. An image-guided drug delivery system (IGDDS), as a real-time noninvasive imaging assessment of therapeutic response, has the strong potential to improve the diagnosis and treatment of cancer because its imaging property offers the quantification of nanomedicine at the intended disease sites, the possible assurance of adequate treatment and elimination of undesirable delay of early-stage diagnosis due to low resolution. One of potential modality that overcomes these challenges could be the nanoconfinement of gold (Au) nanoparticles within other nanoparticles called "Particle-in-Particle (PIP)", which is a strong candidate of cancer treatment because of its "theranostic (therapy + diagnostics)" advantages including imaging (e.g., CT) and therapeutic hyperthermia application. In this review, we will elaborate on the current application of theranostic by nanoconfinement. Then, we will narrow down the gold nanoparticle-mediated theranostic application and its nanoconfinement advantages. Finally, the future direction for maximum nanoconfinement mediated cancer therapy will be included.
Collapse
Affiliation(s)
- Changsun Kang
- Department of Pharmaceutical Sciences, Rangel College of Pharmacy, Texas A&M University, College Station, USA
| | - Dongin Kim
- Department of Pharmaceutical Sciences, Rangel College of Pharmacy, Texas A&M University, College Station, USA.
| |
Collapse
|
9
|
Wu C, Zhou Y, Wang H, Hu J, Wang X. Formation of antifouling functional coating from deposition of a zwitterionic-co-nonionic polymer via “grafting to” approach. JOURNAL OF SAUDI CHEMICAL SOCIETY 2019. [DOI: 10.1016/j.jscs.2019.05.011] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|
10
|
Song D, Cui J, Ju Y, Faria M, Sun H, Howard CB, Thurecht KJ, Caruso F. Cellular Targeting of Bispecific Antibody-Functionalized Poly(ethylene glycol) Capsules: Do Shape and Size Matter? ACS APPLIED MATERIALS & INTERFACES 2019; 11:28720-28731. [PMID: 31369234 DOI: 10.1021/acsami.9b10304] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
In the present study, a capsule system that consists of a stealth carrier based on poly(ethylene glycol) (PEG) and functionalized with bispecific antibodies (BsAbs) is introduced to examine the influence of the capsule shape and size on cellular targeting. Hollow spherical and rod-shaped PEG capsules with tunable aspect ratios (ARs) of 1, 7, and 18 were synthesized and subsequently functionalized with BsAbs that exhibit dual specificities to PEG and epidermal growth factor receptor (EGFR). Dosimetry (variation between the concentrations of capsules present and capsules that reach the cell surface) was controlled through "dynamic" incubation (i.e., continuously mixing the incubation medium). The results obtained were compared with those obtained from the "static" incubation experiments. Regardless of the incubation method and the capsule shape and size studied, BsAb-functionalized PEG capsules showed >90% specific cellular association to EGFR-positive human breast cancer cells MDA-MB-468 and negligible association with both control cell lines (EGFR negative Chinese hamster ovary cells CHO-K1 and murine macrophages RAW 264.7) after incubation for 5 h. When dosimetry was controlled and the dose concentration was normalized to the capsule surface area, the size or shape had a minimal influence on the cell association behavior of the capsules. However, different cellular internalization behaviors were observed, and the capsules with ARs 7 and 18 were, respectively, the least and most optimal shape for achieving high cell internalization under both dynamic and static conditions. Dynamic incubation showed a greater impact on the internalization of rod-shaped capsules (∼58-67% change) than on the spherical capsules (∼24-29% change). The BsAb-functionalized PEG capsules reported provide a versatile particle platform for the evaluation and comparison of cellular targeting performance of capsules with different sizes and shapes in vitro.
Collapse
Affiliation(s)
- Danzi Song
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
| | - Jiwei Cui
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
- Key Laboratory of Colloid and Interface Chemistry of the Ministry of Education, School of Chemistry and Chemical Engineering , Shandong University , Jinan , Shandong 250100 , China
| | - Yi Ju
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
| | - Matthew Faria
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
| | - Huanli Sun
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
| | - Christopher B Howard
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology , The University of Queensland , St. Lucia , Queensland 4072 , Australia
| | - Kristofer J Thurecht
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology , The University of Queensland , St. Lucia , Queensland 4072 , Australia
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
| |
Collapse
|
11
|
Guo Y, Wang T, Qiu H, Han M, Dong Z, Wang X, Wang Y. Hydroxycamptothecin nanoparticles based on poly/oligo (ethylene glycol): Architecture effects of nanocarriers on antitumor efficacy. Eur J Pharm Biopharm 2019; 134:178-184. [DOI: 10.1016/j.ejpb.2018.12.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2018] [Revised: 11/14/2018] [Accepted: 12/04/2018] [Indexed: 12/12/2022]
|
12
|
Chen L, Glass JJ, De Rose R, Sperling C, Kent SJ, Houston ZH, Fletcher NL, Rolfe BE, Thurecht KJ. Influence of Charge on Hemocompatibility and Immunoreactivity of Polymeric Nanoparticles. ACS APPLIED BIO MATERIALS 2018; 1:756-767. [DOI: 10.1021/acsabm.8b00220] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
| | - Joshua J. Glass
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, Australia
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia
| | - Robert De Rose
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, Australia
- ARC Centre of Excellence in Convergent BioNano Science and Technology, Monash University, Melbourne, Victoria 3800, Australia
| | - Claudia Sperling
- Institute Biofunctional Polymer Materials, Max Bergmann Center of Biomaterials, Leibniz-Institut für Polymerforschung Dresden e.V., Dresden D-01069, Germany
| | - Stephen J. Kent
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Melbourne, Australia
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia
- Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University, Melbourne, Victoria 3800, Australia
| | | | | | | | | |
Collapse
|
13
|
Zhao Y, Houston ZH, Simpson JD, Chen L, Fletcher NL, Fuchs AV, Blakey I, Thurecht KJ. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics. Mol Pharm 2017; 14:3539-3549. [DOI: 10.1021/acs.molpharmaceut.7b00560] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Yongmei Zhao
- Centre for Advanced Imaging,
Australian Institute for Bioengineering and Nanotechnology, and ARC
Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, Brisbane, 4072, Australia
| | - Zachary H. Houston
- Centre for Advanced Imaging,
Australian Institute for Bioengineering and Nanotechnology, and ARC
Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, Brisbane, 4072, Australia
| | - Joshua D. Simpson
- Centre for Advanced Imaging,
Australian Institute for Bioengineering and Nanotechnology, and ARC
Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, Brisbane, 4072, Australia
| | - Liyu Chen
- Centre for Advanced Imaging,
Australian Institute for Bioengineering and Nanotechnology, and ARC
Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, Brisbane, 4072, Australia
| | - Nicholas L. Fletcher
- Centre for Advanced Imaging,
Australian Institute for Bioengineering and Nanotechnology, and ARC
Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, Brisbane, 4072, Australia
| | - Adrian V. Fuchs
- Centre for Advanced Imaging,
Australian Institute for Bioengineering and Nanotechnology, and ARC
Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, Brisbane, 4072, Australia
| | - Idriss Blakey
- Centre for Advanced Imaging,
Australian Institute for Bioengineering and Nanotechnology, and ARC
Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, Brisbane, 4072, Australia
| | - Kristofer J. Thurecht
- Centre for Advanced Imaging,
Australian Institute for Bioengineering and Nanotechnology, and ARC
Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, Brisbane, 4072, Australia
| |
Collapse
|
14
|
Zhang C, Moonshi SS, Han Y, Puttick S, Peng H, Magoling BJA, Reid JC, Bernardi S, Searles DJ, Král P, Whittaker AK. PFPE-Based Polymeric 19F MRI Agents: A New Class of Contrast Agents with Outstanding Sensitivity. Macromolecules 2017. [DOI: 10.1021/acs.macromol.7b01285] [Citation(s) in RCA: 44] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Cheng Zhang
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Qld 4072, Australia
- ARC Centre of
Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, Brisbane, Qld 4072, Australia
| | - Shehzahdi Shebbrin Moonshi
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Qld 4072, Australia
- ARC Centre of
Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, Brisbane, Qld 4072, Australia
| | | | - Simon Puttick
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Qld 4072, Australia
- ARC Centre of
Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, Brisbane, Qld 4072, Australia
| | - Hui Peng
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Qld 4072, Australia
- ARC Centre of
Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, Brisbane, Qld 4072, Australia
| | - Bryan John Abel Magoling
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Qld 4072, Australia
| | - James C. Reid
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Qld 4072, Australia
| | - Stefano Bernardi
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Qld 4072, Australia
| | - Debra J. Searles
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Qld 4072, Australia
- School
of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Qld 4072, Australia
| | - Petr Král
- Department
of Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Andrew K. Whittaker
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Qld 4072, Australia
- ARC Centre of
Excellence in Convergent Bio-Nano Science and Technology, The University of Queensland, Brisbane, Qld 4072, Australia
| |
Collapse
|
15
|
Ardana A, Whittaker AK, Thurecht KJ. Synthesis and post-polymerisation ligations of PEG-based hyperbranched polymers for RNA conjugation via reversible disulfide linkage. Macromol Res 2017. [DOI: 10.1007/s13233-017-5111-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
|
16
|
Zhao W, Ta HT, Zhang C, Whittaker AK. Polymerization-Induced Self-Assembly (PISA) - Control over the Morphology of 19F-Containing Polymeric Nano-objects for Cell Uptake and Tracking. Biomacromolecules 2017; 18:1145-1156. [DOI: 10.1021/acs.biomac.6b01788] [Citation(s) in RCA: 75] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Wei Zhao
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, St. Lucia, Queensland 4072, Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Brisbane, Queensland 4072, Australia
| | - Hang T. Ta
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, St. Lucia, Queensland 4072, Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Brisbane, Queensland 4072, Australia
| | - Cheng Zhang
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, St. Lucia, Queensland 4072, Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Brisbane, Queensland 4072, Australia
| | - Andrew K. Whittaker
- Australian
Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, St. Lucia, Queensland 4072, Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Brisbane, Queensland 4072, Australia
| |
Collapse
|
17
|
Wang K, Peng H, Thurecht KJ, Whittaker AK. Fluorinated POSS‐Star Polymers for
19
F MRI. MACROMOL CHEM PHYS 2016. [DOI: 10.1002/macp.201600084] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- Kewei Wang
- Australian Institute for Bioengineering and Nanotechnology and Centre for Advanced Imaging The University of Queensland St. Lucia Queensland 4072 Australia
| | - Hui Peng
- Australian Institute for Bioengineering and Nanotechnology and Centre for Advanced Imaging The University of Queensland St. Lucia Queensland 4072 Australia
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology The University of Queensland St. Lucia Queensland 4072 Australia
| | - Kristofer J. Thurecht
- Australian Institute for Bioengineering and Nanotechnology and Centre for Advanced Imaging The University of Queensland St. Lucia Queensland 4072 Australia
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology The University of Queensland St. Lucia Queensland 4072 Australia
| | - Andrew K. Whittaker
- Australian Institute for Bioengineering and Nanotechnology and Centre for Advanced Imaging The University of Queensland St. Lucia Queensland 4072 Australia
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology The University of Queensland St. Lucia Queensland 4072 Australia
| |
Collapse
|
18
|
Wei X, Luo Q, Sun L, Li X, Zhu H, Guan P, Wu M, Luo K, Gong Q. Enzyme- and pH-Sensitive Branched Polymer–Doxorubicin Conjugate-Based Nanoscale Drug Delivery System for Cancer Therapy. ACS APPLIED MATERIALS & INTERFACES 2016; 8:11765-78. [PMID: 27102364 DOI: 10.1021/acsami.6b02006] [Citation(s) in RCA: 72] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Xiaoli Wei
- Huaxi MR Research Center (HMRRC),
Department of Radiology, ‡Laboratory of Stem Cell Biology, State Key Laboratory
of BiotherapyWest, and §Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041,China
| | - Qiang Luo
- Huaxi MR Research Center (HMRRC),
Department of Radiology, ‡Laboratory of Stem Cell Biology, State Key Laboratory
of BiotherapyWest, and §Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041,China
| | - Ling Sun
- Huaxi MR Research Center (HMRRC),
Department of Radiology, ‡Laboratory of Stem Cell Biology, State Key Laboratory
of BiotherapyWest, and §Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041,China
| | - Xue Li
- Huaxi MR Research Center (HMRRC),
Department of Radiology, ‡Laboratory of Stem Cell Biology, State Key Laboratory
of BiotherapyWest, and §Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041,China
| | - Hongyan Zhu
- Huaxi MR Research Center (HMRRC),
Department of Radiology, ‡Laboratory of Stem Cell Biology, State Key Laboratory
of BiotherapyWest, and §Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041,China
| | - Pujun Guan
- Huaxi MR Research Center (HMRRC),
Department of Radiology, ‡Laboratory of Stem Cell Biology, State Key Laboratory
of BiotherapyWest, and §Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041,China
| | - Min Wu
- Huaxi MR Research Center (HMRRC),
Department of Radiology, ‡Laboratory of Stem Cell Biology, State Key Laboratory
of BiotherapyWest, and §Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041,China
| | - Kui Luo
- Huaxi MR Research Center (HMRRC),
Department of Radiology, ‡Laboratory of Stem Cell Biology, State Key Laboratory
of BiotherapyWest, and §Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041,China
| | - Qiyong Gong
- Huaxi MR Research Center (HMRRC),
Department of Radiology, ‡Laboratory of Stem Cell Biology, State Key Laboratory
of BiotherapyWest, and §Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041,China
| |
Collapse
|
19
|
Ulbrich K, Holá K, Šubr V, Bakandritsos A, Tuček J, Zbořil R. Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies. Chem Rev 2016; 116:5338-431. [DOI: 10.1021/acs.chemrev.5b00589] [Citation(s) in RCA: 1120] [Impact Index Per Article: 140.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Karel Ulbrich
- Institute
of Macromolecular Chemistry, The Czech Academy of Sciences, v.v.i., Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| | - Kateřina Holá
- Regional
Centre of Advanced Technologies and Materials, Department of Physical
Chemistry, Faculty of Science, Palacky University, 17 Listopadu 1192/12, 771 46 Olomouc, Czech Republic
| | - Vladimir Šubr
- Institute
of Macromolecular Chemistry, The Czech Academy of Sciences, v.v.i., Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| | - Aristides Bakandritsos
- Regional
Centre of Advanced Technologies and Materials, Department of Physical
Chemistry, Faculty of Science, Palacky University, 17 Listopadu 1192/12, 771 46 Olomouc, Czech Republic
| | - Jiří Tuček
- Regional
Centre of Advanced Technologies and Materials, Department of Physical
Chemistry, Faculty of Science, Palacky University, 17 Listopadu 1192/12, 771 46 Olomouc, Czech Republic
| | - Radek Zbořil
- Regional
Centre of Advanced Technologies and Materials, Department of Physical
Chemistry, Faculty of Science, Palacky University, 17 Listopadu 1192/12, 771 46 Olomouc, Czech Republic
| |
Collapse
|
20
|
Sun L, Li X, Wei X, Luo Q, Guan P, Wu M, Zhu H, Luo K, Gong Q. Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents. ACS APPLIED MATERIALS & INTERFACES 2016; 8:10499-512. [PMID: 27043102 DOI: 10.1021/acsami.6b00980] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Ling Sun
- Huaxi MR Research Center
(HMRRC), Department of Radiology, West China Hospital and ‡Laboratory of Stem
Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
| | - Xue Li
- Huaxi MR Research Center
(HMRRC), Department of Radiology, West China Hospital and ‡Laboratory of Stem
Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
| | - Xiaoli Wei
- Huaxi MR Research Center
(HMRRC), Department of Radiology, West China Hospital and ‡Laboratory of Stem
Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
| | - Qiang Luo
- Huaxi MR Research Center
(HMRRC), Department of Radiology, West China Hospital and ‡Laboratory of Stem
Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
| | - Pujun Guan
- Huaxi MR Research Center
(HMRRC), Department of Radiology, West China Hospital and ‡Laboratory of Stem
Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
| | - Min Wu
- Huaxi MR Research Center
(HMRRC), Department of Radiology, West China Hospital and ‡Laboratory of Stem
Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
| | - Hongyan Zhu
- Huaxi MR Research Center
(HMRRC), Department of Radiology, West China Hospital and ‡Laboratory of Stem
Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
| | - Kui Luo
- Huaxi MR Research Center
(HMRRC), Department of Radiology, West China Hospital and ‡Laboratory of Stem
Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
| | - Qiyong Gong
- Huaxi MR Research Center
(HMRRC), Department of Radiology, West China Hospital and ‡Laboratory of Stem
Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
| |
Collapse
|
21
|
He Q, Guo S, Qian Z, Chen X. Development of individualized anti-metastasis strategies by engineering nanomedicines. Chem Soc Rev 2015; 44:6258-6286. [PMID: 26056688 PMCID: PMC4540626 DOI: 10.1039/c4cs00511b] [Citation(s) in RCA: 89] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Metastasis is deadly and also tough to treat as it is much more complicated than the primary tumour. Anti-metastasis approaches available so far are far from being optimal. A variety of nanomedicine formulae provide a plethora of opportunities for developing new strategies and means for tackling metastasis. It should be noted that individualized anti-metastatic nanomedicines are different from common anti-cancer nanomedicines as they specifically target different populations of malignant cells. This review briefly introduces the features of the metastatic cascade, and proposes a series of nanomedicine-based anti-metastasis strategies aiming to block each metastatic step. Moreover, we also concisely introduce the advantages of several promising nanoparticle platforms and their potential for constructing state-of-the-art individualized anti-metastatic nanomedicines.
Collapse
Affiliation(s)
- Qianjun He
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu 610041, P. R. China.
- Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
| | - Shengrong Guo
- School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, P. R. China
| | - Zhiyong Qian
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu 610041, P. R. China.
| | - Xiaoyuan Chen
- Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
| |
Collapse
|
22
|
Fuchs AV, Tse BW, Pearce AK, Yeh MC, Fletcher NL, Huang SS, Heston WD, Whittaker AK, Russell PJ, Thurecht KJ. Evaluation of Polymeric Nanomedicines Targeted to PSMA: Effect of Ligand on Targeting Efficiency. Biomacromolecules 2015; 16:3235-47. [DOI: 10.1021/acs.biomac.5b00913] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
| | - Brian W.C. Tse
- Australian
Prostate Cancer Research Centre − Queensland, Institute of
Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Brisbane 4102, Australia
| | | | - Mei-Chun Yeh
- Australian
Prostate Cancer Research Centre − Queensland, Institute of
Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Brisbane 4102, Australia
| | | | - Steve S. Huang
- Department
of Nuclear Medicine, Cleveland Clinic, Cleveland, Ohio 44195, United States
| | - Warren D. Heston
- Department
of Cancer Biology, Cleveland Clinic, Cleveland, Ohio 44195, United States
| | | | - Pamela J. Russell
- Australian
Prostate Cancer Research Centre − Queensland, Institute of
Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Brisbane 4102, Australia
| | | |
Collapse
|
23
|
Lowe S, O'Brien-Simpson NM, Connal LA. Antibiofouling polymer interfaces: poly(ethylene glycol) and other promising candidates. Polym Chem 2015. [DOI: 10.1039/c4py01356e] [Citation(s) in RCA: 330] [Impact Index Per Article: 36.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
This review highlights antibiofouling polymer interfaces with emphasis on the latest developments using poly(ethylene glycol) and the design new polymeric structures.
Collapse
Affiliation(s)
- Sean Lowe
- Department of Chemical and Biomolecular Engineering
- The University of Melbourne
- Victoria
- Australia 3010
| | | | - Luke A. Connal
- Department of Chemical and Biomolecular Engineering
- The University of Melbourne
- Victoria
- Australia 3010
| |
Collapse
|